检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]湖北省宣恩县人民医院内分泌科,湖北宣恩445500
出 处:《中国现代医生》2015年第34期28-30,共3页China Modern Doctor
摘 要:目的观察门诊患者胰岛素强化治疗对高血糖控制的影响,从而探索难治性糖尿病血糖达标的门诊管理方案。方法选择2011年5月~2015年6月在本院住院的62例难治性糖尿病患者,出院时血糖基本达标。其中34例为治疗组,出院后继续在门诊维持胰岛素强化治疗,其余28例为对照组,出院后使用口服药物或者2次预混胰岛素治疗。治疗3个月后比较两组患者的血糖控制达标率、低血糖发生事件等情况。结果与对照组比较,强化治疗组FPG、2h PG及Hb A1c指标控制更平稳(P〈0.05),血糖达标率更高(P〈0.05),低血糖事件发生率更低(P〈0.05)。结论多次皮下胰岛素注射强化治疗是难治性糖尿病患者有效、安全的治疗方案,并且此方案适宜在门诊管理和推广。Objective To observe the effects of insulin intensive treatment on the control of hyperglycemia in the patients in outpatient clinics, so as to explore the management protocol of blood glucose up to standard in refractory diabetes. Methods A total of 62 patients with refractory diabetes who were hospitalized in our hospital from May 2011 to June 2015 were selected, and their blood glucose level was basically up to standard upon discharge. 34 of them were in treatment group, were further given maintenance intensive insulin therapy in the Outpatient Clinic after discharge, and28 of them were in the control group, who were given oral medication or 2 times of pre-mixed insulin therapy. The standard rate of blood glucose con trol and events of hypoglycemia were compared between the two groups of patients 3months after the treatment. Results There was statistical significance in the comparison between intensive treatment group and control group. The control of FPG, 2h PG and Hb A1 c indicators was more stable(P〈0.05), the standard rate of blood glucose was higher(P〈0.05) and the incidence rate of hypoglycemia was lower(P〈0.05). Conclusion Intensive treatment of multiple subcutaneous in sulin injection is an effective and safe treatment protocol for patients with refractory diabetes, and this protocol is appropriate for management and promotion in outpatient clinics.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.232